SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-20-019267
Filing Date
2020-11-12
Accepted
2020-11-12 13:56:22
Documents
2
Period of Report
2020-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 6057
2 POWER OF ATTORNEY poa.htm EX-24.1 4427
  Complete submission text file 0001567619-20-019267.txt   11868
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INMED PHARMACEUTICALS INC. SUITE 310 - 815 HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address
HULL ANDREW (Reporting) CIK: 0001818252 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 201305600